Skip to content

Investigate the effect of Juniperus Capsules on Severity of Postpartum Pain in Multiparous Women

Investigate the effect of Juniperus Capsules on Severity of Postpartum Pain in Multiparous Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100130003226N23
Enrollment
70
Registered
2024-11-18
Start date
2024-11-30
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum pain. Pelvic and perineal pain

Interventions

Intervention 1: Intervention group: 2 hours after delivery, every 8 hours to 24 hours, one capsule containing 500 mg of Juniperus powder is given and half an hour, one hour and two hours after each in

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 45 years At least be able to read and write. vaginal delivery Pregnancy age between 37 and 40 weeks So the labor pain is moderate to severe Delivery should not be operative Absence of grade 3 and 4 perineal tears No history of chronic diseases No history of caesarean section and abdominal incision Not using epidural and spinal anesthesia during labor and delivery No drug addiction A healthy and single baby Absence of birth complications in the mother Second, third and fourth births The baby weighs between 2,500 and 4,000 gr The placenta and fetus have been removed spontaneously

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study The occurrence of drug sensitivity Using housings other than the studied housings

Design outcomes

Primary

MeasureTime frame
Postpartum pain. Timepoint: Before the intervention - half an hour, one hour and two hours after the intervention. Method of measurement: Using a McGill pain ruler.

Secondary

MeasureTime frame
Side effects of the drug. Timepoint: After the intervention. Method of measurement: Drug side effects questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahrogh Dolatian

Shahid Beheshti University of Medical Sciences

m_dolatian@sbmu.ac.ir+98 21 4913 1678

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026